Pallas Capital Advisors LLC Takes $211,000 Position in Maximus, Inc. $MMS

Key Points

• Pallas Capital Advisors LLC has taken a new position in Maximus, Inc., acquiring 3,008 shares valued at approximately $211,000 during the 2nd quarter.
• Analysts have upgraded Maximus from a "hold" to a "strong-buy" rating, with a consensus rating of "Strong Buy" and an average price target of $90.00.
• Maximus declared a quarterly dividend of $0.30 per share, resulting in an annualized dividend yield of 1.4%.

Pallas Capital Advisors LLC acquired a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,008 shares of the health services provider's stock, valued at approximately $211,000.

Other hedge funds have also made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Maximus by 35.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 168,936 shares of the health services provider's stock valued at $12,611,000 after acquiring an additional 44,182 shares during the last quarter. Total Wealth Planning & Management Inc. acquired a new position in shares of Maximus in the fourth quarter valued at approximately $259,000. Wealthedge Investment Advisors LLC purchased a new position in Maximus in the 4th quarter valued at $222,000. 111 Capital purchased a new position in Maximus in the 4th quarter valued at $361,000. Finally, GAMMA Investing LLC grew its position in Maximus by 11,296.1% in the 1st quarter. GAMMA Investing LLC now owns 49,915 shares of the health services provider's stock valued at $3,404,000 after buying an additional 49,477 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Strong Buy" and an average price target of $90.00.

Maximus Price Performance

Maximus stock opened at $88.79 on Tuesday. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.94. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The business has a fifty day moving average of $81.89 and a two-hundred day moving average of $74.09. The company has a market cap of $5.00 billion, a P/E ratio of 16.35 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the business posted $1.74 earnings per share. The firm's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Sunday, August 31st. Stockholders of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus's payout ratio is 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.